- Report
- March 2025
- 50 Pages
Global
From €2529EUR$2,650USD£2,119GBP
Chlormethine Hydrochloride is a chemical compound used in the treatment of certain types of cancer. It is a nitrogen mustard alkylating agent, meaning it works by attaching itself to the DNA of cancer cells, preventing them from replicating and causing them to die. It is used in combination with other drugs to treat Hodgkin's lymphoma, non-Hodgkin's lymphoma, and certain types of leukemia. It is also used to treat some types of brain tumors.
Chlormethine Hydrochloride is available in both generic and branded forms. It is typically administered intravenously or intramuscularly, and is available in various concentrations. It is also available in combination with other drugs, such as cyclophosphamide and vincristine.
The Chlormethine Hydrochloride market is highly competitive, with a number of companies offering products. Some of the major players in the market include Bristol-Myers Squibb, Pfizer, Merck, Novartis, and Teva Pharmaceuticals. Show Less Read more